Purpose. The antimicrobial activity of N-chlorotaurine (NCT), an endogenous long-lived oxidant applied topically, was tested against Chlamydiae in vitro.
INTRODUCTION
N-chlorotaurine (NCT), the N-chloro derivative of the amino acid taurine, is an endogenous long-lived oxidant, which is thought to exert immune-regulatory and antimicrobial properties during inflammation [1, 2] . The sodium salt of N-chlorotaurine (Cl-HN-CH 2 -CH 2 -SO 3 -Na, NCT) can be synthesized chemically and is soluble in water [3] . The 1 % (w/v) aqueous solution of NCT has broad-spectrum bactericidal, fungicidal, virucidal and protozoocidal activity [4] . Because of its mild oxidizing properties, NCT proved to be very well tolerated by human tissue and can be used topically at different body sites to treat infections, e.g. in the human eye, on the skin, in the ear and paranasal sinuses, in the oral cavity, and in the urinary tract (for a review see [4] ). Recently, inhalation therapy has become a field of interest [5] [6] [7] [8] .
Pulmonary, orbital as well as vaginal and urinary tract infections can be caused by the different species of Chlamydiae [9] . They are treated with antibiotics, mainly macrolides, tetracyclins and quinolones [10, 11] . Although it is a rare phenomenon so far in Chlamydiae, resistance against antibiotics has been detected against all substance classes in use [12, 13] . Additionally, long-term infections occur probably due to intracellular formation of persisters in the presence of antibiotics [11, 14] . Because of these reasons, the development of new anti-infectives active against Chlamydiae, preferably with a different mechanism of action, is of interest. Basically, some chlamydial infection sites could be conceived for topical treatment with NCT. One example is keratoconjunctivitis, where NCT can be used as eye drops [15, 16] . As another example, C. pneumoniae causes acute respiratory infections like pneumonia, sinusitis, bronchitis and it is supposed to be associated with the development of chronic obstructive pulmonary disease and asthma [17, 18] . Thus, inhalative therapy might support the treatment and prevention of infection with C. pneumoniae.
It was the aim of this study to test the in vitro activity of NCT against elementary and reticulate bodies of Chlamydia spp., which were recently shown to possess a functional peptidoglycan wall [19] .
METHODS

Bacteria and test substance
For verifying NCT activity against Chlamydia pneumoniae, we tested a strain known to induce acute as well as chronic infection, the coronary artery isolate CV-6, recovered from a chronically infected atheromatous lesion [20] . For Chlamydia trachomatis, we chose clinical isolates of the frequently encountered serovars A and D (isolates provided by Matthias Maaß). C. pneumoniae were propagated as described earlier [21, 22] and stored at À80 C until use. Bacteria were thawn and added to heteroploid line (HL) cells at an m.o.i. of 30. After infection, cells were washed with PBS twice before medium was added again.
Pure NCT as a crystalline sodium salt (molecular weight 181.57) was prepared as previously described and purity was proven by spectrophotometry [3] . NCT was dissolved in 10 mM PBS (pH 7.1-7.2) to avoid reduction of the active chlorine that occurs with reducing components in culture media and serum components [23] .
Activity of NCT against extracellular Chlamydia spp.
Immunofluorescence To investigate loss of infectivity, Chlamydiae were treated with NCT and re-grown in epithelial cells subsequent to inactivation of NCT. Purified bacteria were tenfold diluted in NCT solutions in PBS to final numbers of 1Â10 7 C. pneumoniae inclusion forming units (i.f.u.) ml À1 and 10 3 -10 4 i.f.u. ml À1 for C. trachomatis, respectively, and to final concentrations of 1 % (w/v, 55 mM), 0.1 and 0.01 % NCT. These solutions were then incubated for 1, 10, 20, 30 or 60 min at 37 C in a water bath. Negative controls with PBS incubated for 60 min and positive controls with 70 % ethanol in PBS incubated for 10 min were done in parallel. Subsequently, aliquots of 10 µl (samples containing 1 % NCT or ethanol) or 100 µl (controls and samples containing 0.1 and 0.01 % NCT) were diluted in 990 µl and 900 µl RPMI (Roswell Park Memorial Institute) 1640, respectively, plus 2 mM L-glutamine and 10 % fetal calf serum (FCS) and added to confluent HL (kindly donated by Mika Paldanius, Oulu, Finland) or HepG2 (ATCC CCL-23) cells in RPMI medium plus 10 % FCS at an m.o.i. of 30. NCT was sufficiently inactivated by this dilution as comparative tests applying 3 % (w/v) sodium thiosulfate for inactivation at the end of the incubation time revealed similar results. Moreover, viability of the cell culture was not affected by the diluted NCT as proven by the absence of lactate dehydrogenase (LDH) release. The NCT-incubated chlamydial inoculum was centrifuged (500 g for 45 min, 37 C) onto the cell monolayers. The medium was changed after centrifugation. Inoculated cells were grown for 72 h. For visualization of chlamydial infection, cell monolayers were fixed in methanol and stained with fluoresceine-isothiocyanate (FITC)-conjugated anti-Chlamydia lipopolysaccharide (LPS) monoclonal antibody (OXOID (Ely), Ely, UK). Chlamydial inclusions within cells were counted by fluorescence microscopy at a magnification of Â200 with a Scope A1 microscope (Zeiss, emission 515 nm, extinction 450-490 nm). Five representative visual fields were counted for all samples, and the number of i.f.u. per visual field was calculated. In cases of <5 i.f.u. per visual field, the whole culture spot was monitored. The detection limit was 10 i.f.u. ml À1 for controls and samples containing 0.1 and 0.01 % NCT and 100 i.f.u. ml À1 for samples with 1 % NCT according to this procedure.
To confirm that the NCT-treated Chlamydiae were irreversibly inactivated and incapable of infectivity and regrowth, a second passage progeny was cultivated. For this, in a further series of experiments, cells were inoculated with NCT-or mock-treated elementary bodies. After incubation for 72 h at 37 C, inclusion bodies were isolated by lysing the cells by vortexing with glass beads (4 mm, Lenz Laborglas GmbH, Wertheim, Germany) for 4 min. Subsequent to centrifugation for 5 min at 1250 g, they were added to fresh HL cell monolayers and incubated for another 72 h. To visualize the chlamydial infection, coverslips overlayed with HL cells were fixed and stained as described above. Inclusion bodies of five visual fields were counted and quantification of chlamydial infection was performed with real-time quantitative PCR. Each experiment was performed independently for three to eight times, and all titrations were carried out in duplicate.
Real-time quantitative PCR
To confirm the absence of multiplication of Chlamydiae after treatment with NCT on a genetic level, DNA copies were determined by real-time quantitative PCR (qPCR). From the first and second passage progeny of the tests with immunofluorescence mentioned in the previous paragraph, C. pneumoniae inclusion bodies grown for 3 days in the cells were isolated with guanidine-thiocyanate/phenol mixture (Peqgold trifast; Peqlab, Polling, Austria) [24] . Cells were washed twice with PBS and bacterial DNA was extracted with SsoFast EVAGREEN Supermix (BioRad) and prepared according to the manufacturers' protocol. We performed a 23S-based Chlamydiaceae family specific real-time qPCR as described [24, 25] . All TaqMan probes and primers were obtained from Microsynth (Microsynth AG, Balgach, Switzerland). Amplification conditions for Chlamydiae were 95 C for 2 min, followed by 40 cycles of 95 C for 0.05 min and 62 C for 0.05 min. The following primers and probes were used for the experiments described: Clamydia_ ArgR_pro:
5¢-AAGAGAGGCGTTATGGCGAATAGA-GAGCA-3¢, Clamydia_ArgR_fw: 5¢-ACCAGGAACCG TACGAATTACAA-3¢, Clamydia_ArgR_rv: 5´-GACCAC-GACCCGTCATTTG-3´; the amplification of the 16SrRNA gene served as the quality control: 16S_fw: 5´-TGTAGCGG TGAAATGCGTAG-3´, 16 s_rv:
Activity of NCT against intracellular Chlamydia pneumoniae Purified C. pneumoniae were added to confluent HL cells in RPMI medium plus 10 % FCS at an m.o.i. of 30. The chlamydial inoculum was centrifuged (500 g for 45 min, 37 C) onto the cell monolayers. The medium was changed after centrifugation. Inoculated cells were grown for 24 h. Then, the medium was removed and replaced by 0.025, 0.05, 0.07 or 0.1 % NCT in PBS or plain PBS as a negative control. Incubation times at 37 C were 30 and 60 min. Subsequently, NCT was removed and replaced by RPMI plus FCS. Then, 8 and 24 h later, a similar further incubation in NCT was performed.
This regimen was performed to simulate repeated application of NCT. At the end, NCT was again replaced by medium, and the cells were grown for an additional 24 h. Then, they were fixed, stained and subjected to immunofluorescence as mentioned above. Chlamydial inclusions were counted under the fluorescence microscope at a magnification of Â200 with a Scope A1 microscope (Zeiss). (Fig. 1a) . Inclusions could also be seen in 70-90 % of the cells inoculated with C. pneumoniae treated with PBS after 72 h of growth (negative controls without NCT, n=8,
Statistical analysis
). By contrast, NCT caused a concentration-and time-dependent reduction of C. pneumoniae infection (Fig. 1a) . In Chlamydiae treated with 1 % (55 mM) NCT for 1, 30 or 60 min, 0.1 % NCT for 1, 30 or 60 min, or 70 % ethanol for 3 min (positive control), no inclusions could be found (n=8), indicating loss of infectivity. Treatment with 0.1 % NCT for 1 min reduced the number of infected cells by 90.0±11.6 % (mean values±SD, n=5). Lowering the concentration of NCT to 0.01 % resulted in chlamydial growth similar to the controls after 1 and 30 min (Table 1) , while inclusions disappeared completely after 60 min incubation time (reduction of i.f.u. by >99.4±0.4 %, n=6).
Prolonged infection and infectious progeny assay
Prolonged infection of the inoculated cells for 144 h did not change this result, except for the fact that in negative controls up to 95 % of the cells were stained positive for C. pneumoniae inclusions (n=3). The same was true for experiments with high numbers of chlamydial i.f.u.
(1.7Â10 7 ml
À1
) and second passage infection after lysis of the host cells (Fig. 1c) . In these tests, no fluorescent inclusions could be detected after infection with bacteria treated with 1 % NCT for 1-60 min or with 0.1 % NCT for 30 and 60 min or with 0.01 % NCT for 60 min, whereas in controls an overwhelming infection was seen. Thus, loss of infectivity/viability of C. pneumoniae following NCT treatment was confirmed.
Real-time qPCR
These results for C. pneumoniae were also confirmed by real-time qPCR where full chlamydial DNA-replication was found in controls to a high extent, whereas in samples incubated in 0.1 and 1 % NCT relatively low numbers of chlamydial DNA copies were detected (Fig. 1b) . These effects were similar for second passage progeny (Fig. 1d) .
Activity of NCT against extracellular C. trachomatis NCT at concentrations of 0.1 and 1 % prevented infection with C. trachomatis serovars A and D after a minimal incubation time of 1 min (Table 1) . Exposure to 0.01 % NCT for up to 30 min did not interfere with the formation of intracellular inclusions. These results were identical for chlamydial inocula of either 10 3 or 10 4 i.f.u. ml 
DISCUSSION
Rapid reduction of infection and killing of the obligate intracellular Chlamydiae by millimolar concentrations of NCT at 37 C is a novel finding and in agreement with previous observations on the antimicrobial activity of NCT against extracellular bacteria. NCT kills Gram-positive and Gram-negative bacteria generally within a few minutes at 37 C [2, 4] . Moreover, it has been shown that within 1 min chlorination of the surface of bacteria and fungi takes place with subsequent loss of virulence [4, 26] . Since adhesion and entry into host cells are fundamental for replication of Chlamydiae, we assume that these steps are blocked by a rapid oxidation of chlamydial surface molecules, such as type III secretion machinery components or polymorphic outer membrane proteins. This would explain the absence of infectivity of Chlamydiae after brief exposure to NCT. However, surface chlorination and loss of virulence are reversible after regrowth of bacteria treated with sublethal concentration/incubation time of NCT [27] . Irreversible inactivation of bacteria is connected with penetration of active chlorine into the cytosol of the micro-organisms and oxidation of numerous intracellular proteins [28, 29] . In the present study, NCT was inactivated at the end of the incubation time as required in killing assays with antiseptics, and Chlamydiae were regrown in cell culture free from the antiseptic. Moreover, to ensure any theoretical influence of reaction products of NCT, tests with a second passage of Chlamydiae in cell culture were done. Since in these tests Table 1 . Inactivation of Chlamydiae by NCT still no growth occurred after sufficient pre-incubation time in NCT, irreversible inactivation of these bacteria, too, has been demonstrated.
NCT can be safely applied to the eye and apparently also to the lung at a concentration of 1 % (55 mM) [6, 7, 16] . Since already a short incubation with a tenfold lower concentration strongly affects the chlamydial infectivity, it is suggestive to consider this substance also for topical treatment of infections caused by Chlamydia trachomatis. Eye infections can be treated by repeated dropping of NCT [15, 16] , which may be of interest for treatment of trachoma. Vaginal and urinary tract infections refractory to conventional treatment could be treated by local irrigations [30] . Concerning respiratory infections, the inhalative route of NCT application could be useful to cure bronchitis [5] [6] [7] [8] . The broad spectrum of antimicrobial activity of NCT including bacteria, viruses and fungi [4] appears to be of advantage.
It has to be taken into account that Chlamydiae multiply intracellularly. Presently, it remains unclear if inclusion bodies could be reached by NCT during inflammation in vivo. Previous clinical studies, particularly in purulent ulcerations of the skin and external otitis, demonstrated good efficacy, although causative bacteria may multiply within the infected tissues [4] . Therefore, inactivation of pathogens exposed on surfaces can be sufficient for topical treatment, or some penetration of active chlorine into the tissue plays a role as seen in the eye [15] . In the case of Chlamydiae, inactivation of the released elementary bodies would interrupt the growth cycle of these microbes and thus prevent the subsequent infection of neighbouring cells. Moreover, our in vitro tests disclosed that NCT -already at concentrations that did not kill the host cells -can inactivate intracellular Chlamydiae. It may be hypothesized that this is the case in vivo, too, since the NCT-concentration that can be applied clinically without moderate adverse effects is at least tenfold higher (1 %). Nevertheless, efficacy of NCT against Chlamydiae in vivo remains to be clarified with respective animal models and clinical studies.
At an inflammation site, NCT equilibrates with amino acids, peptides and proteins to form the corresponding N-chloramines (transchlorination, [31, 32] ). Upon reaction with ammonium ions, monochloramine (NH 2 Cl) is formed (NH 3 +NCT ! NH 2 Cl+taurine), which is more lipophilic, penetrates cells at a much higher rate than NCT and has a higher microbicidal activity [31, 32] . Probably, the formation of monochloramine and also of some N-chloro-amino acids enhances the bactericidal activity of NCT at the site of its application in vivo, while chlorine transfer to proteins has rather the opposite effect [4, 33] . Based on our encouraging in vitro results, it will be important to study the efficacy of NCT in chlamydial infections in vivo. According to the previous clinical studies with different pathogens, beneficial effects could be verified in vivo repeatedly [4, 33] . Compared to antibiotics, advantages of NCT against Chlamydiae, too, would be activity against all strains, absence of resistance development, endogenous occurrence, high tolerability without systemic distribution or toxicity, and improbability of allergic reactions as an endogenous amino acid derivative [4] . As an antiseptic, however, NCT can be applied only topically, which restricts its indications to body sites accessible to this kind of therapy. Compared to other active chlorine compounds, which have generally markedly higher oxidative activity, NCT as a mild oxidant has the advantage of better tolerability and therefore applicability of higher concentrations. The latter enables chlorine consumption to be overcome and transchlorination to be exploited for an improved antimicrobial activity [34, 35] .
To conclude, this study proves the bactericidal effect of millimolar NCT against C. pneumoniae and C. trachomatis. Therefore, NCT could be conceived as an anti-infective agent for topical treatment of infections with Chlamydiae, for instance in the eye and bronchopulmonary system. Its usability for such indications remains to be tested in respective in vivo studies.
Funding information
This study has been supported by the Austrian Science Fund, grant no. KLI459-B30 (M. N.) and by the Austrian FFG/GEN-AU initiative within the ERA-NET PathoGenoMics ChlamyTrans (M. M.).
